Clinical Trial Update: Desvenlafaxine Monotherapy in Dysthymia [NA]

View source ↗

Summary

A completed clinical trial evaluating desvenlafaxine as monotherapy for dysthymia (persistent depressive disorder).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Depressive Disorder

Drugs mentioned

• Desvenlafaxine (Desvenlafaxine)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Dysthymic Disorder | NA | Status: COMPLETED